Trial NCT04552366
Publication Wu S, Lancet, 2021
Primary outcome on the report: 1) Occurrence of adverse events within 7 days after each vaccination. 2) Anti-SARS-CoV-2 spike receptor IgG antibody and SARS-CoV-2 neutralising antibody geometric mean concentrations and titres at day 28 after last vaccination.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.